[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112017017457A2 - composição hemostática e dispositivo hemostático (variantes) - Google Patents

composição hemostática e dispositivo hemostático (variantes)

Info

Publication number
BR112017017457A2
BR112017017457A2 BR112017017457-0A BR112017017457A BR112017017457A2 BR 112017017457 A2 BR112017017457 A2 BR 112017017457A2 BR 112017017457 A BR112017017457 A BR 112017017457A BR 112017017457 A2 BR112017017457 A2 BR 112017017457A2
Authority
BR
Brazil
Prior art keywords
hemostatic
composition
variants
agents
hemostatic device
Prior art date
Application number
BR112017017457-0A
Other languages
English (en)
Inventor
Ihor Volodymyrovych Gaiovych
Volodimir Mykolayovych Granich
Iaroslav Viktorovych Kyshenia
Petro Andriyovych Manoryk
Vadym Borysovych Mazevych
Svitlana Oleksandrivna Sotnik
Igor Sergiyovych Tsurupa
Original Assignee
Ihor Volodymyrovych Gaiovych
Volodimir Mykolayovych Granich
Iaroslav Viktorovych Kyshenia
Petro Andriyovych Manoryk
Vadym Borysovych Mazevych
Svitlana Oleksandrivna Sotnik
Igor Sergiyovych Tsurupa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from UAA201501285A external-priority patent/UA115667C2/uk
Priority claimed from UAU201501288U external-priority patent/UA101868U/uk
Application filed by Ihor Volodymyrovych Gaiovych, Volodimir Mykolayovych Granich, Iaroslav Viktorovych Kyshenia, Petro Andriyovych Manoryk, Vadym Borysovych Mazevych, Svitlana Oleksandrivna Sotnik, Igor Sergiyovych Tsurupa filed Critical Ihor Volodymyrovych Gaiovych
Publication of BR112017017457A2 publication Critical patent/BR112017017457A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/54—Radio-opaque materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

composição hemostática que compreende agentes hemostáticos inorgânicos e orgânicos de supressão de poeira de aglutinante e retenção de água e do dispositivo hemostático que compreende a composição de agentes hemostáticos e um recipiente que mantém a composição hemostática.
BR112017017457-0A 2015-02-16 2016-02-15 composição hemostática e dispositivo hemostático (variantes) BR112017017457A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
UAU201501288 2015-02-16
UAA201501285 2015-02-16
UAA201501285A UA115667C2 (uk) 2015-02-16 2015-02-16 Гемостатична композиція та гемостатичний засіб (варіанти)
UAU201501288U UA101868U (xx) 2015-02-16 2015-02-16 Гемостатична композиція
PCT/UA2016/000019 WO2016133483A1 (en) 2015-02-16 2016-02-15 Hemostatic composition and hemostatic device (variants)

Publications (1)

Publication Number Publication Date
BR112017017457A2 true BR112017017457A2 (pt) 2018-04-10

Family

ID=55809163

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017457-0A BR112017017457A2 (pt) 2015-02-16 2016-02-15 composição hemostática e dispositivo hemostático (variantes)

Country Status (23)

Country Link
US (1) US20180236123A1 (pt)
EP (1) EP3258974A1 (pt)
JP (1) JP2018506410A (pt)
KR (1) KR20170118198A (pt)
CN (1) CN107454851A (pt)
AU (1) AU2016220560A1 (pt)
BR (1) BR112017017457A2 (pt)
CA (1) CA2975464A1 (pt)
CL (1) CL2017002086A1 (pt)
CO (1) CO2017008219A2 (pt)
CR (1) CR20170379A (pt)
CU (1) CU20170107A7 (pt)
DO (1) DOP2017000192A (pt)
EA (1) EA201791857A1 (pt)
IL (1) IL254012A0 (pt)
MX (1) MX2017010458A (pt)
NI (1) NI201700103A (pt)
PE (1) PE20180230A1 (pt)
PH (1) PH12017501490A1 (pt)
SG (1) SG11201706720WA (pt)
TN (1) TN2017000345A1 (pt)
WO (1) WO2016133483A1 (pt)
ZA (1) ZA201706256B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
CN107789022B (zh) * 2016-08-31 2019-12-20 王洛 链式快速止血装置
EP3532026B1 (en) 2016-10-27 2022-07-13 El Sabahy, Mahmoud, Fahmy Ali Nanotechnology-based hemostatic dressings
WO2018116052A1 (en) * 2016-12-20 2018-06-28 Innovative Nano & Micro Technologies Pvt Ltd (Inm Technologies), Scaffold compositions for tissue repair
CN107213508B (zh) * 2017-06-09 2018-04-06 中南大学 一种含铁氧化物/纳米高岭土复合止血剂及其制备方法
KR102368895B1 (ko) * 2017-08-23 2022-03-02 코오롱인더스트리 주식회사 접착제 조성물, 이를 포함하는 접착제 및 이의 제조방법
CA3082000A1 (en) * 2017-12-15 2019-06-20 Toray Industries, Inc. Woven fabric and method for manufacturing same
CN108294797B (zh) * 2018-01-03 2019-09-03 王洛 快速止血装置的制造方法
CN108294798B (zh) * 2018-01-03 2020-09-25 王洛 带导丝的快速止血装置
CN108030529B (zh) * 2018-01-03 2020-06-19 王洛 带气囊的快速止血装置
US11666532B2 (en) 2018-01-19 2023-06-06 Hyloris Developments Sa Tranexamic acid oral solution
US20210220184A1 (en) * 2018-08-03 2021-07-22 Anne's Day Ltd Absorbent tampon for treatment of menstrual symptoms
CN109172857A (zh) * 2018-09-10 2019-01-11 中国药科大学 一种外创用复合止血材料及其制备方法
IL262716A (en) 2018-11-01 2018-11-29 Omrix Biopharmaceuticals Ltd Oxidized cellulose preparations
CN111249516B (zh) * 2018-12-01 2020-12-22 浙江大学 一种含胰蛋白酶的止血织物及其制备方法
CN109620999A (zh) * 2019-01-12 2019-04-16 王若梅 一种复合止血医用组织胶的制备方法
EP3917584A1 (en) * 2019-01-28 2021-12-08 Hyprotek, Inc. Antimicrobial composition with procoagulant, immunomodulatory, and tissue regenerative properties
JP7389418B2 (ja) * 2019-02-18 2023-11-30 青葉化成株式会社 止血剤
CN111714687A (zh) * 2019-03-19 2020-09-29 广东博与再生医学有限公司 一种骨止血材料及其制备方法
CN111714683B (zh) * 2019-03-19 2023-04-18 陕西佰傲再生医学有限公司 一种骨止血材料及其制备方法
KR102366423B1 (ko) * 2019-03-20 2022-02-22 한남대학교 산학협력단 대량 출혈을 신속하게 제어할 수 있는 생분해성 고분자를 용액방사에 적용한 지혈 시스템
KR102220182B1 (ko) * 2019-09-02 2021-02-25 김형훈 관절경 출혈 컨트롤장치
US20210106717A1 (en) * 2019-10-10 2021-04-15 Cook Medical Technologies Llc Bonded powders for the treatment of bodily lesions
CN110721334B (zh) * 2019-11-26 2021-02-02 中南大学湘雅二医院 一种止血创伤敷料及其制备方法
FR3105501B1 (fr) 2019-12-24 2022-07-29 Atos Integration Système d’assistant personnel vocal pour une gestion de dialogue avec une application d’invitations exécutables
KR102302405B1 (ko) * 2020-01-07 2021-09-16 주식회사 테라시온 바이오메디칼 마이크로-비드 및 그 제조방법, 이를 포함하는 지혈 드레싱의 제조방법
US11654057B2 (en) 2020-04-09 2023-05-23 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same
KR20220009198A (ko) * 2020-07-15 2022-01-24 이시우 비강 패킹 구조체
CN112472416A (zh) * 2020-11-24 2021-03-12 天长市康特美防护用品有限公司 一种一次性吸血腋垫
CN114796592B (zh) * 2021-01-21 2023-09-08 重庆理工大学 一种壳聚糖基抑菌凝胶剂的制备方法
US20220323635A1 (en) * 2021-04-06 2022-10-13 The United States Of America, As Represented By The Secretary Of Agriculture Fabric compositions comprising attached ascorbic acid
CN113144277B (zh) * 2021-04-13 2022-06-14 武汉理工大学 一种可注射流体明胶及其制备方法和应用
CN113425889B (zh) * 2021-06-25 2023-01-24 延安大学 一种抗菌止血海绵及其制备方法和应用
CN113520627B (zh) * 2021-07-23 2022-10-18 亚都控股集团有限公司 一种能够被多重智能识别的医用棉纱垫或纱布叠片及其制备方法
KR102630826B1 (ko) * 2021-10-18 2024-01-29 주식회사 파인메딕스 지혈제 분사기
CN114045587B (zh) * 2021-11-10 2022-09-02 武汉纺织大学 基于亲水改性壳聚糖的复合纱线止血材料
CN114343974A (zh) * 2022-01-08 2022-04-15 良药控股集团江苏医疗用品有限公司 一种预防新创伤疤痕形成医用水凝抗菌敷料
US11642324B1 (en) 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof
CN114805555A (zh) * 2022-04-12 2022-07-29 湖南农业大学 一种从血浆中提取免疫球蛋白IgG的方法
CN115721775B (zh) * 2022-12-09 2023-09-29 海南苏生生物科技有限公司 一种复合改性生物水凝胶敷料及其制备工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2350628A1 (en) * 1998-11-12 2000-05-18 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
AU2006214371A1 (en) * 2005-02-15 2006-08-24 Virginia Commonwealth University Mineral technologies (MT) for acute hemostasis and for the treatment of acute wounds and chronic ulcers
US20070154509A1 (en) * 2005-12-30 2007-07-05 Wilcher Steve A Adsorbent-Containing Hemostatic Devices
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7968114B2 (en) 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US8202532B2 (en) 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
DE102008005469A1 (de) * 2008-01-21 2009-07-23 Kettenbach Gmbh & Co. Kg Pastöses Einsetzmaterial zur Erweiterung des Zahnfleischsulcus und dessen Verwendung
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
PT2863961T (pt) * 2012-06-22 2018-11-30 Z Medica Llc Dispositivos hemostáticos

Also Published As

Publication number Publication date
PH12017501490A1 (en) 2018-01-29
AU2016220560A1 (en) 2017-09-21
EA201791857A1 (ru) 2018-02-28
US20180236123A1 (en) 2018-08-23
CL2017002086A1 (es) 2018-03-16
TN2017000345A1 (en) 2019-01-16
DOP2017000192A (es) 2017-11-15
CR20170379A (es) 2018-01-25
CO2017008219A2 (es) 2018-01-05
CA2975464A1 (en) 2016-08-25
MX2017010458A (es) 2018-04-24
PE20180230A1 (es) 2018-01-31
SG11201706720WA (en) 2017-09-28
ZA201706256B (en) 2019-02-27
IL254012A0 (en) 2017-10-31
WO2016133483A1 (en) 2016-08-25
JP2018506410A (ja) 2018-03-08
EP3258974A1 (en) 2017-12-27
CN107454851A (zh) 2017-12-08
CU20170107A7 (es) 2018-07-05
KR20170118198A (ko) 2017-10-24
NI201700103A (es) 2017-09-11
AU2016220560A8 (en) 2017-09-28

Similar Documents

Publication Publication Date Title
BR112017017457A2 (pt) composição hemostática e dispositivo hemostático (variantes)
CL2017000649A1 (es) Composiciones que contengan células de bacilo recombinantes y un insecticida
CL2016002772A1 (es) Composiciones de insulina de rápida acción
CL2017000660A1 (es) Composiciones que contengan células de bacilo recombinantes y un fungicida
UY37036A (es) Compuestos inhibidores de la quinasa de unión a tank
DK3397631T3 (da) Substituerede 3-azabicyclo[3.1.0]hexaner som ketohexokinase-inhibitorer
BR112017008666A2 (pt) anticorpos anti-fgfr2/3 e métodos de uso dos mesmos
BR112017005266A2 (pt) inibidores de mk2 e uso dos mesmos
BR112017005379A2 (pt) composições que compreendem células recombinantes de bacillus e um fungicida.
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
UY36330A (es) Compuestos inhibidores de quinasa de unión a tank
BR112017005504A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
FR3026308B1 (fr) Dispositif de diffusion d'au moins un agent volatil
CL2016001210A1 (es) Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis.
CL2020000154A1 (es) Compuestos absorbentes
MA50612A (fr) Utilisation de compositions contenant desstreptomyces mélanosporofaciens
CO2017011295A2 (es) Piroglutamato de vortioxetina
ES2674521T8 (es) Procedimiento para el curado de resina UP o VE que contiene met(acrilato)
ES1216222Y (es) Composicion que comprende cenizas de cremacion
CL2015002389A1 (es) Composiciones herbicidas que contienen isoxabena y flufenaceto.
CL2016001977A1 (es) Composición que comprende igm derivada de plasma y su uso para el tratamiento o prevención de afecciones inmunitarias.
CL2015000610A1 (es) Derivados de isoxazolidina
DOS2017000251S (es) Funda (embalaje)
MA51426A (fr) Dispositif de protection de récipients
NO20161136A1 (en) Compounds and compositions for biofilm prevention

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]